Juan José Espinós

ORCID: 0000-0003-4838-8940
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Ovarian function and disorders
  • Reproductive System and Pregnancy
  • Assisted Reproductive Technology and Twin Pregnancy
  • Pregnancy and preeclampsia studies
  • Reproductive Biology and Fertility
  • Extracellular vesicles in disease
  • Endometriosis Research and Treatment
  • Growth Hormone and Insulin-like Growth Factors
  • Maternal and fetal healthcare
  • Reproductive Health and Technologies
  • Pituitary Gland Disorders and Treatments
  • Reproductive Health and Contraception
  • Ectopic Pregnancy Diagnosis and Management
  • Gestational Diabetes Research and Management
  • Birth, Development, and Health
  • Sexual Differentiation and Disorders
  • Hormonal and reproductive studies
  • Lipid metabolism and disorders
  • Adrenal and Paraganglionic Tumors
  • Gynecological conditions and treatments
  • Prenatal Screening and Diagnostics
  • Adrenal Hormones and Disorders
  • Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities
  • Sex and Gender in Healthcare
  • Steroid Chemistry and Biochemistry

Universitat Autònoma de Barcelona
1999-2024

Institut d'Investigació Biomédica de Bellvitge
2022

Hospital de Sant Pau
2008-2022

Centre for Biomedical Network Research on Rare Diseases
2013-2014

Valencian Infertility Institute
2010

Parc de Salut
2010

Iberoamerican Cochrane Centre
2010

Universitat de Barcelona
1992

Objective: Our objective was to test the efficacy and tolerability of three doses flutamide (125, 250, 375 mg) combined with a triphasic oral contraceptive (ethynylestradiol/levonorgestrel) during 12 months treat moderate severe hirsutism in patients polycystic ovary syndrome or idiopathic hirsutism.

10.1210/jc.2006-2798 article EN The Journal of Clinical Endocrinology & Metabolism 2007-06-14

The transmission of DNA through extracellular vesicles (EVs) represents a novel genetic material transfer mechanism that may impact genome evolution and tumorigenesis. We aimed to investigate the potential for vertical within maternal endometrial EVs pre-implantation embryo describe any effect on bioenergetics. discovered human endometrium secretes all three general subtypes EV - apoptotic bodies (ABs), microvesicles (MVs), exosomes (EXOs) into fluid (EF) uterine cavity. become uniformly...

10.7554/elife.88008 article EN cc-by eLife 2023-06-23

Abstract: The aim of this study is to evaluate the feasibility and safety random-start controlled ovarian hyperstimulation (COH) for emergency fertility preservation, regardless phase menstrual cycle. A self-controlled pilot clinical trial (NCT01385332) was performed in an acute-care teaching hospital two private reproductive centers Barcelona, Spain. Eleven egg donors participated study. Two gonadotropin-releasing hormone (GnRH) antagonist protocols were assessed which ganirelix initiated...

10.2147/ijwh.s66743 article EN cc-by-nc International Journal of Women s Health 2015-02-01

AbstractObjective The aim of this study was to evaluate the demographic characteristics population attending our hospital requesting postcoital contraception and determine effectiveness method its side-effects.Methods A total 503 women asking for were included in a prospective open trial. After filling questionnaire dealing with contraceptive data, we prescribed an ethinylestradiol-levonorgestrel combination (100 μg/ 500 mg two doses 12 h apart).Results Only 487 available analysis data....

10.3109/13625189909043477 article EN The European Journal of Contraception & Reproductive Health Care 1999-01-01

Abstract Purpose To describe the clinical characteristics, management and pregnancy outcome of women with prepregnancy hypopituitarism (HYPO) that received care at our center. Methods Retrospective study describing 12 pregnancies in HYPO (two or more pituitary hormonal deficiencies under replacement treatment) during Hospital Santa Creu i Sant Pau. Clinical were systematically collected. Results Average patients’ age was 35 years duration beginning 19 years. The most frequent cause surgical...

10.1007/s11102-021-01196-7 article EN cc-by Pituitary 2021-11-30

To test the hypothesis that macroprolactinemia is an extra-pituitary phenomenon by showing pituitary production of prolactin in patients with hyperprolactinemia due to macroprolactin comparable normoprolactinemic women and different from monomeric hyperprolactinemia.Twenty-five were studied: eight hyperprolactinemia, nine controls. Prolactin levels measured before after precipitation polyethylene glycol at baseline 5, 10,15, 30, 60 min metoclopramide administration (10 mg i.v.) three...

10.1080/09513590.2016.1222363 article EN Gynecological Endocrinology 2016-11-12

Emergency contraception (EC) accessibility has evolved differently in Catalunya as compared with other autonomous communities Spain. Free-of-charge access within the Public Health System was authorised 2004, and over-the-counter (OTC) implemented 2009. The aim of study is to assess impact these measures on demand users' profiles at our institution.A retrospective study, Department, conducted evaluate EC requests relationship modifications. age women which days week they attended were...

10.3109/13625187.2014.913787 article EN The European Journal of Contraception & Reproductive Health Care 2014-05-28

Abstract Study question Are anti-Müllerian hormone (AMH) levels predictive of cumulative pregnancy rate in non-infertile women undergoing intrauterine insemination with donor sperm (ds-IUI)? Summary answer AMH has limited value for clinical after 4 cycles ds-IUI women. Decreased concentration does not necessarily reduce rates. What is known already Physiologically, rates decline due to oocyte quality deterioration upon advancing maternal age. a widely-used marker ovarian reserve and...

10.1093/humrep/deae108.1014 article EN Human Reproduction 2024-07-01

Abstract Study question Does OXO-001 increase implantation and pregnancy rates in women undergoing egg donation IVF/ICSI embryo transfer (ET) compared to placebo? Summary answer This proof-of-concept (PoC) prospective randomized controlled study shows that treatment increases infertile with studied doses. What is known already a drug being developed as an innovative enhance through direct effect on the endometrium. Preclinical results show viability. Moreover, they safe for mother, fetuses,...

10.1093/humrep/deae108.027 article EN Human Reproduction 2024-07-01
Coming Soon ...